Found 19 matching trials
Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464
PHASE1A two part, fixed-sequence, open-label crossover study to evaluate potentia...
Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis
PHASE2This Phase IIa study aims at investigating the safety and tolerability of 2...
Location
Cliniques Universitaires Saint-Luc
Safety and Pharmacokinetics Study in Healthy Japanese Volunteers
PHASE1The study consists of Part A, a randomized double-blind, single-ascending-d...
Location
Medical Corporation Heishinkai OPHAC Hospital
ABX464 First in Man Study
PHASE1This study is an open label, parallel group, single ascending dose, explora...
ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
PHASE2This Phase IIa study is an 8-week, double-blind, placebo-controlled, random...
Location
Univ.-Klinik für Innere Medizin I
A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
PHASE1The purpose of the ABX464-005 study is to characterize the systemic and muc...
Location
Hospital Universitari Germans Trias i Pujol
ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19
PHASE2A phase 2/3, randomized, double blind, placebo-controlled study to evaluate...
Location
Centre hospitalier Saint Pierre
Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
PHASE2This study is an open-label study aiming at evaluating the long-term safety...
Status
Active Not Recruiting
Location
Medizinische Universitaet Innsbruck
ABTECT - Maintenance
PHASE3This is a multicenter, randomized, placebo-controlled study to evaluate the...
Status
Active Not Recruiting
Location
Digestive Health Specialists of the Southeast
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
PHASE3This is a multicenter, randomized, placebo controlled study to evaluate the...
Location
Digestive Health Specialists of the Southeast